KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Tenet Healthcare (THC) Equity Income (2016 - 2025)

Historic Equity Income for Tenet Healthcare (THC) over the last 12 years, with Q4 2025 value amounting to $83.0 million.

  • Tenet Healthcare's Equity Income rose 641.03% to $83.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $264.0 million, marking a year-over-year increase of 153.85%. This contributed to the annual value of $264.0 million for FY2025, which is 153.85% up from last year.
  • Tenet Healthcare's Equity Income amounted to $83.0 million in Q4 2025, which was up 641.03% from $64.0 million recorded in Q3 2025.
  • Tenet Healthcare's 5-year Equity Income high stood at $83.0 million for Q4 2025, and its period low was $42.0 million during Q1 2021.
  • Moreover, its 5-year median value for Equity Income was $57.5 million (2024), whereas its average is $59.3 million.
  • As far as peak fluctuations go, Tenet Healthcare's Equity Income skyrocketed by 75555.56% in 2021, and later crashed by 1558.44% in 2022.
  • Over the past 5 years, Tenet Healthcare's Equity Income (Quarter) stood at $77.0 million in 2021, then decreased by 15.58% to $65.0 million in 2022, then rose by 12.31% to $73.0 million in 2023, then grew by 6.85% to $78.0 million in 2024, then increased by 6.41% to $83.0 million in 2025.
  • Its Equity Income stands at $83.0 million for Q4 2025, versus $64.0 million for Q3 2025 and $61.0 million for Q2 2025.